novel precision drugs that target the tumor microenvironment
Oncomatryx Capital increase 2022

Published by EXPANSIÓN 2022-03-08 Oncomatryx has carried out a capital increase of 15 million euros to start clinical trials with people with invasive tumors in Spain and the USA.